Genetic Screening for Sperm Donors Explained
Learn how genetic screening for sperm donors works, what carrier screening looks for, what positive results mean, and how donor and recipient results are compared.
When choosing a sperm donor, genetic screening can sound reassuring but also confusing.
A profile might say that a donor has completed an expanded carrier panel, tested negative for certain conditions, or is a carrier for one or more genetic variants. It is easy to assume that a donor with a positive carrier result is somehow less suitable than one with completely negative results.
That is usually not how carrier screening works.
Many healthy people carry recessive genetic variants without ever developing the associated condition. The important question is often whether the donor and the other genetic parent carry variants affecting the same condition.
Genetic screening helps identify those risks before conception.
What is genetic carrier screening?
Carrier screening looks for genetic variants associated with inherited conditions.
For many autosomal recessive conditions, a person can carry one altered copy of a gene while remaining completely healthy.
The reproductive risk becomes more significant when both genetic parents carry disease-causing variants in the same gene.
If both are carriers of the same autosomal recessive condition, each pregnancy generally has a:
- 25% chance of an affected child;
- 50% chance of a child who is a carrier;
- 25% chance of a child who inherits neither variant.
That is why a donor's result should not always be viewed in isolation.
The result becomes most useful when it is considered alongside the genetic information of the person contributing the egg.
What conditions are sperm donors tested for?
The answer depends on the country, sperm bank, clinic, and testing panel.
In the U.S., current ASRM guidance recommends that all sperm and egg donors undergo carrier screening for cystic fibrosis, spinal muscular atrophy, and hemoglobin disorders such as sickle-cell disease and thalassemias. ASRM also states that broader expanded carrier screening may be appropriate and recommends pan-ethnic screening rather than relying only on a person's reported ethnicity.
Many commercial donor programs test for far more conditions than this minimum recommendation.
Expanded carrier panels may analyze dozens or even hundreds of genes, depending on the laboratory and test used.
That does not necessarily mean that the largest panel is always the best. The important thing is understanding which conditions were tested and whether the donor and recipient were tested using compatible panels.
How does genetic screening work in Europe?
There is no single identical donor-screening panel used across every European country.
EU rules require genetic screening for autosomal recessive genes known to be prevalent in the donor's ethnic background and an assessment of the risk of inherited conditions known to exist in the donor's family. Member states can impose additional requirements.
Individual European sperm banks and fertility clinics may therefore perform broader screening than the regulatory baseline.
This is why two donors available through different European programs can have very different genetic information attached to their profiles.
If you are comparing donors internationally, check exactly what each program means by “genetically screened.”
What about genetic screening in the UK?
UK fertility clinics also assess sperm donors for inherited conditions and take personal and family medical history into account.
However, genetic testing practices can vary according to the donor's history, the clinic, and the conditions being considered.
As with the U.S. and EU, a donor being accepted into a program does not mean that every conceivable genetic condition has been ruled out.
No screening panel can do that.
The useful question is therefore not simply, “Was this donor genetically tested?”
Ask what they were tested for.
What is expanded carrier screening?
Traditional carrier screening often targeted particular conditions based on ancestry or family history.
Expanded carrier screening uses a larger panel and tests many conditions at once.
ASRM currently favors pan-ethnic expanded carrier screening over relying solely on ethnicity-based panels, partly because people increasingly have mixed ancestry and because uncommon recessive conditions can occur in any population.
This approach can provide more consistent information across donors.
But expanded screening also increases the likelihood of finding carrier results.
That is not necessarily bad news.
Finding a carrier variant allows the fertility team to assess whether it creates a meaningful reproductive risk.
Is a donor who is a carrier automatically rejected?
Usually not.
Being a carrier of a recessive condition does not necessarily affect the donor's health and does not automatically make the donor unsuitable.
ASRM specifically states that donors who are heterozygous carriers of autosomal recessive conditions that do not pose health risks to carriers do not necessarily need to be excluded.
Instead, the next step may be to test the person providing the egg for the same condition.
If they are not a carrier of a disease-causing variant in that gene, the risk of having an affected child may be very low, although no genetic test reduces risk to zero.
This is why automatically rejecting every donor with a positive carrier result can unnecessarily eliminate suitable donors.
Why should the intended parent sometimes be tested too?
Donor screening only provides half of the genetic picture.
Suppose a donor is found to carry a variant for cystic fibrosis.
That result becomes much more meaningful when you know whether the person providing the egg is also a carrier.
ASRM recommends counseling recipients about donor carrier-screening results and giving the relevant reproductive partner the option of carrier testing. When a donor carries a recessive condition, the reproductive implications should be explained before proceeding.
Ideally, both people are screened for the same conditions or the results are reviewed professionally if different testing panels were used.
Why can different genetic panels be difficult to compare?
Not every laboratory tests the same genes.
Even when two laboratories test for the same condition, they may use different methods or look for different variants.
For example, one donor may have been screened using a 100-gene panel while another was tested using several hundred genes.
That does not automatically make the second donor safer.
ASRM recommends that, where possible, the sperm and egg sources be screened for the same conditions. If different panels were used, a genetics professional can review the reports and determine whether additional testing is needed.
This is particularly relevant when using sperm from an international bank and receiving fertility treatment somewhere else.
Family history is still important
Genetic testing does not replace a detailed family history.
Some inherited conditions may not be included on standard carrier panels. Other conditions may follow dominant or X-linked inheritance patterns rather than the recessive pattern commonly targeted by carrier screening.
ASRM recommends obtaining a three-generation family history from donors where possible and having concerning patterns evaluated by a genetics professional.
For example, repeated cases of an unusual disease, multiple unexplained miscarriages, certain cancers at unusually young ages, intellectual disability, or known genetic disorders in close relatives may justify further investigation.
A donor with an extensive testing panel but poorly documented family history does not necessarily provide more useful genetic information than someone whose overall history has been assessed carefully.
Are chromosomes tested too?
Not routinely in every donor.
A karyotype looks at the number and structure of chromosomes and can identify rearrangements such as translocations.
ASRM considers routine karyotyping of every donor optional when there are no concerning risk factors. However, it recommends considering chromosome testing when the donor or their family has a history suggesting a possible chromosome abnormality—for example recurrent pregnancy loss, stillbirths, certain birth defects, infertility, or a known chromosome rearrangement in a close relative.
Again, screening is tailored partly to what the donor's history reveals.
Can genetic screening predict intelligence, personality, or appearance?
Not in the way donor shoppers sometimes imagine.
Medical genetic screening is primarily intended to identify risks for inherited diseases and conditions.
It is not a reliable tool for predicting whether a child will be highly intelligent, athletic, musical, outgoing, tall, or successful.
Traits such as personality, cognitive ability, height, and appearance usually involve complicated interactions between many genes and environmental influences.
That is fundamentally different from carrier screening for a well-defined inherited disorder.
When comparing donor profiles, do not confuse medical genetic testing with an attempt to design a child's future characteristics.
What does a negative genetic test mean?
A negative result is reassuring, but it does not mean there is zero genetic risk.
No panel tests for every possible disease-causing variant.
Tests also have different detection rates, and science continues to discover new gene-disease relationships over time.
ASRM therefore emphasizes residual risk—the possibility that someone may still be a carrier even after receiving a negative result.
This is another reason genetic screening should be viewed as risk reduction rather than a guarantee.
What if a donor's family develops a genetic condition later?
Genetic information can change after donation.
A donor might later receive a diagnosis, or a sibling or parent might develop a condition that turns out to have a hereditary component.
ASRM recommends that donors update clinics or agencies when important new family or medical information becomes available.
When choosing a sperm bank, it is worth asking how it handles medical and genetic updates.
Does it recontact families?
Can donors provide updated information years later?
Are records retained so donor-conceived people can access relevant information in the future?
These systems can matter just as much as the original screening panel.
What about a known sperm donor?
A known donor should receive the same serious genetic consideration as someone selected through a sperm bank.
If you meet a donor through Banbino, through friends, or through another private route, knowing their identity does not tell you their carrier status.
A fertility clinic or genetic counselor can help arrange appropriate screening and compare the donor's results with those of the intended genetic parent.
This is one reason donor discovery and medical approval should remain separate stages.
Banbino can help you find someone whose background, characteristics, and family-building intentions fit what you are looking for. Genetic suitability should then be evaluated professionally.
What should you ask about a donor's genetic screening?
When reviewing a donor profile, useful questions include:
What genetic panel was used?
How many and which conditions were included?
Was a detailed family history also reviewed?
Was additional testing performed because of family history?
Is the donor a carrier for anything?
Should the person providing the egg be tested for the same condition?
Were both genetic parents tested using comparable panels?
Can the donor's genetic information be updated later?
These questions tell you much more than a simple green checkmark beside “genetically screened.”
Genetic screening is about compatibility, not perfection
It can be tempting to search for a donor with no positive findings.
But genetics rarely works that neatly.
A healthy donor may carry one or more recessive variants. Another donor may receive an entirely negative panel while still having residual genetic risks that the test cannot detect.
The goal is not to find someone with supposedly perfect genes.
It is to identify meaningful reproductive risks, compare the donor's results with those of the other genetic parent, investigate relevant family history, and make an informed decision with appropriate professional guidance.
That makes genetic screening an important part of choosing a sperm donor—but only one part of the wider picture.